GRI Bio, Inc. (GRI)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| — | 8-K (2026-05-14) · 99.1 | |||
| 10-QLatest | Q1-2026 | 8-K (2026-02-04) · 99.1 | ||
| 10-KLatest | FY-2025 | — | ||
| 10-Q | Q3-2025 | — | ||
| 10-Q | Q2-2025 | — | ||
| 10-Q | Q1-2025 | 8-K (2025-05-15) · 99.1 | 8-K (2025-03-17) · 99.1 | ||
| 10-K | FY-2024 | — | ||
| 10-Q | Q3-2024 | 8-K (2024-11-14) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-14) · 99.1 · 99.2 | 8-K (2024-05-13) · 99.1 · 99.2 | ||
| 10-Q | Q1-2024 | 8-K (2024-04-01) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2023-11-15) · 99.1 | ||
| 10-Q | Q3-2023 | — | ||
| 10-Q | Q2-2023 | 8-K (2023-08-14) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Changes In Stockholders Equity | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Changes In Stockholders Equity (deficit) | ||
| Notes | ||
| Accrued Expenses | ||
| Asset Purchase Agreement | ||
| Basis of Presentation and Summary of Significant Accounting Policies | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Fair Value Measurements | ||
| Income Tax | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | — |
|
| Liquidity | ||
| Merger With Vallon | ||
| Organization and Description of Business | ||
| Pay Vs Performance Disclosure | ||
| Promissory Notes | ||
| Property and Equipment | ||
| Segment Reporting | ||
| Stock-based Compensation | ||
| Stockholders Equity | ||
| Stockholders Equity (deficit) | — |
|
| Subsequent Events | ||
| Summary of Significant Accounting Policies | — |
|